Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Possible involvement of silent mutations in cancer pathogenesis and evolution.

Tytuł:
Possible involvement of silent mutations in cancer pathogenesis and evolution.
Autorzy:
Kikutake C; Division of Bioinformatics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan.
Suyama M; Division of Bioinformatics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan. .
Źródło:
Scientific reports [Sci Rep] 2023 May 10; Vol. 13 (1), pp. 7593. Date of Electronic Publication: 2023 May 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: London : Nature Publishing Group, copyright 2011-
MeSH Terms:
Silent Mutation*
Neoplasms*/genetics
Humans ; Evolution, Molecular ; Mutation ; Codon
References:
BMC Cancer. 2021 Apr 9;21(1):388. (PMID: 33836673)
Nucleic Acids Res. 2000 Jan 1;28(1):292. (PMID: 10592250)
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5. (PMID: 20837533)
Nature. 2020 May;581(7809):434-443. (PMID: 32461654)
Cell. 2013 Nov 7;155(4):948-62. (PMID: 24183448)
Nature. 2022 Jun;606(7915):725-731. (PMID: 35676473)
Nat Commun. 2019 Jun 12;10(1):2569. (PMID: 31189880)
PLoS Biol. 2012;10(6):e1001342. (PMID: 22719226)
Oncogene. 2021 Nov;40(45):6309-6320. (PMID: 34584217)
Nucleic Acids Res. 2016 Jan 4;44(D1):D1023-31. (PMID: 26590405)
Genet Res. 1968 Jun;11(3):247-69. (PMID: 5713805)
Nature. 2020 Feb;578(7793):122-128. (PMID: 32025013)
Cell Syst. 2018 Mar 28;6(3):271-281.e7. (PMID: 29596782)
Mol Biol Cell. 2001 Apr;12(4):780-94. (PMID: 11294886)
Am J Hum Genet. 2020 Jul 2;107(1):83-95. (PMID: 32516569)
NAR Cancer. 2021 Mar 22;3(1):zcab008. (PMID: 34316701)
NPJ Genom Med. 2018 Jan 11;3:1. (PMID: 29354286)
Nucleic Acids Res. 1987 Feb 11;15(3):1281-95. (PMID: 3547335)
Hum Mutat. 2018 Mar;39(3):333-344. (PMID: 29266534)
N Engl J Med. 2012 Mar 8;366(10):883-892. (PMID: 22397650)
Am J Med Genet. 1986 Jul;24(3):393-414. (PMID: 2425619)
Nucleic Acids Res. 2018 Jan 4;46(D1):D221-D228. (PMID: 29126148)
Science. 2009 Apr 10;324(5924):218-23. (PMID: 19213877)
Cell. 2015 Mar 12;160(6):1111-24. (PMID: 25768907)
PLoS One. 2016 Aug 11;11(8):e0160463. (PMID: 27513638)
Nature. 2009 Sep 10;461(7261):225-9. (PMID: 19701183)
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2789-94. (PMID: 21282656)
Nucleic Acids Res. 2004 Sep 24;32(17):5036-44. (PMID: 15448185)
EMBO J. 2022 Mar 1;41(5):e109256. (PMID: 35040509)
Oncogene. 2021 Sep;40(37):5600-5612. (PMID: 34312488)
Nat Genet. 2008 Oct;40(10):1163-5. (PMID: 18724368)
Dig Dis Sci. 2012 May;57(5):1247-52. (PMID: 22134786)
Genome Res. 2011 Aug;21(8):1360-74. (PMID: 21659425)
Nat Struct Mol Biol. 2013 Feb;20(2):237-43. (PMID: 23262490)
Mech Dev. 2014 Aug;133:91-104. (PMID: 24878353)
Contemp Oncol (Pozn). 2015;19(1A):A68-77. (PMID: 25691825)
Neuron. 2016 Oct 19;92(2):392-406. (PMID: 27693255)
Nat Rev Genet. 2011 Aug 31;12(10):683-91. (PMID: 21878961)
Nat Rev Mol Cell Biol. 2018 Jan;19(1):20-30. (PMID: 29018283)
PLoS Genet. 2006 Dec;2(12):e221. (PMID: 17194224)
Nat Commun. 2019 Apr 3;10(1):1523. (PMID: 30944313)
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5. (PMID: 24234437)
Substance Nomenclature:
0 (Codon)
Entry Date(s):
Date Created: 20230510 Date Completed: 20230512 Latest Revision: 20230601
Update Code:
20240105
PubMed Central ID:
PMC10172315
DOI:
10.1038/s41598-023-34452-w
PMID:
37165041
Czasopismo naukowe
Recent studies have shown that some silent mutations can be harmful to various processes. In this study, we performed a comprehensive in silico analysis to elucidate the effects of silent mutations on cancer pathogenesis using exome sequencing data derived from the Cancer Genome Atlas. We focused on the codon optimality scores of silent mutations, which were defined as the difference between the optimality of synonymous codons, calculated using the codon usage table. The relationship between cancer evolution and silent mutations showed that the codon optimality score of the mutations that occurred later in carcinogenesis was significantly higher than of those that occurred earlier. In addition, mutations with higher scores were enriched in genes involved in the cell cycle and cell division, while those with lower scores were enriched in genes involved in apoptosis and cellular senescence. Our results demonstrate that some silent mutations can be involved in cancer pathogenesis.
(© 2023. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies